Transient fluid flow improves photoimmunoconjugate delivery and photoimmunotherapy efficacy
- PMID: 37520715
- PMCID: PMC10372742
- DOI: 10.1016/j.isci.2023.107221
Transient fluid flow improves photoimmunoconjugate delivery and photoimmunotherapy efficacy
Abstract
Circulating drugs in the peritoneal cavity is an effective strategy for advanced ovarian cancer treatment. Photoimmunotherapy, an emerging modality with potential for the treatment of ovarian cancer, involves near-infrared light activation of antibody-photosensitizer conjugates (photoimmunoconjugates) to generate cytotoxic reactive oxygen species. Here, a microfluidic cell culture model is used to study how fluid flow-induced shear stress affects photoimmunoconjugate delivery to ovarian cancer cells. Photoimmunoconjugates are composed of the antibody, cetuximab, conjugated to the photosensitizer, and benzoporphyrin derivative. Longitudinal tracking of photoimmunoconjugate treatment under flow conditions reveals enhancements in subcellular photosensitizer accumulation. Compared to static conditions, fluid flow-induced shear stress at 0.5 and 1 dyn/cm2 doubled the cellular delivery of photoimmunoconjugates. Fluid flow-mediated treatment with three different photosensitizer formulations (benzoporphyrin derivative, photoimmunoconjugates, and photoimmunoconjugate-coated liposomes) led to enhanced phototoxicity compared to static conditions. This study confirms the fundamental role of fluid flow-induced shear stress in the anti-cancer effects of photoimmunotherapy.
Keywords: Biotechnology; Cancer; Drug delivery system; Fluidics; Nanotechnology.
© 2023 The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures







Similar articles
-
Overcoming the effects of fluid shear stress in ovarian cancer cell lines: Doxorubicin alone or photodynamic priming to target platinum resistance.Photochem Photobiol. 2024 Nov-Dec;100(6):1676-1693. doi: 10.1111/php.13967. Epub 2024 Jun 7. Photochem Photobiol. 2024. PMID: 38849970
-
Breaking the selectivity-uptake trade-off of photoimmunoconjugates with nanoliposomal irinotecan for synergistic multi-tier cancer targeting.J Nanobiotechnology. 2020 Jan 2;18(1):1. doi: 10.1186/s12951-019-0560-5. J Nanobiotechnology. 2020. PMID: 31898555 Free PMC article.
-
Role of shear stress-induced red blood cell released ATP in atherosclerosis.Am J Physiol Heart Circ Physiol. 2025 Apr 1;328(4):H774-H791. doi: 10.1152/ajpheart.00875.2024. Epub 2025 Feb 21. Am J Physiol Heart Circ Physiol. 2025. PMID: 39982440 Free PMC article.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
-
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090. Health Technol Assess. 2006. PMID: 16545208
Cited by
-
Folate-Targeted Nanoliposomal Chemophototherapy.Pharmaceutics. 2023 Sep 26;15(10):2385. doi: 10.3390/pharmaceutics15102385. Pharmaceutics. 2023. PMID: 37896144 Free PMC article.
-
Engineering photodynamics for treatment, priming and imaging.Nat Rev Bioeng. 2024 Sep;2(9):752-769. doi: 10.1038/s44222-024-00196-z. Epub 2024 Jun 19. Nat Rev Bioeng. 2024. PMID: 39927170 Free PMC article.
-
Overcoming the effects of fluid shear stress in ovarian cancer cell lines: Doxorubicin alone or photodynamic priming to target platinum resistance.Photochem Photobiol. 2024 Nov-Dec;100(6):1676-1693. doi: 10.1111/php.13967. Epub 2024 Jun 7. Photochem Photobiol. 2024. PMID: 38849970
References
-
- Szender J.B., Emmons T., Belliotti S., Dickson D., Khan A.N.M.N., Morrell K., Khan A., Singel K.L., Mayor P.C., Moysich K.B., et al. Impact of ascites volume on clinical outcomes in ovarian cancer: A cohort study. Gynecol. Oncol. 2017;146:491–497. doi: 10.1016/j.ygyno.2017.06.008. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources